期刊文献+

胞外囊泡作为药物传递天然纳米载体的研究进展 被引量:5

The research progress of extracellular vesicles for drug delivery as natural nanocarriers
下载PDF
导出
摘要 细胞释放膦脂膜的小囊泡在细胞交流、抗原递呈、感染物的传递等方面起关键作用。胞外小囊泡携带各种蛋白、mRNA、microRNA(miRNA),象一个卡车运载"货物"一样,将携带的各种分子运载至远端的细胞。而且,被小囊泡包裹的分子可避免被体液中的酶降解,使胞外囊泡成为天然的、新颖的药物传递系统。该文综述了胞外囊泡的分类、组成、生物药物应用、以及作为药物传递载体在临床实验应用等方面的研究进展,为寻求新的药物传递系统治疗相关疾病提供理论基础。 Phospholipid membrane vesicles from cells play key roles in cell communication, antigen presentation, and transmis-sion of infectious agents. Extracellular vesicles ( EVs) carry vari-ous proteins, mRNA, and microRNA( miRNA) , like a truck to bring different molecular cargoes to remote cells. Furthermore, the encapsulated molecules by EVs can be prevented from being degraded by enzymes in body fluids, making EVs as a natural,novel drug delivery system. In this paper, we review the pro-gress of EVs for biological application and drug delivery vehicles from the classification and composition, which provides a theo-retical basis for seeking new drug delivery systems for the treat-ment of diseases.
出处 《中国药理学通报》 CAS CSCD 北大核心 2017年第6期757-760,共4页 Chinese Pharmacological Bulletin
基金 江苏省自然科学基金资助项目(No BK20141295) 江苏省“333工程”项目(No BRA2014172) 镇江市社会发展项目(No SH2015033) 镇江市重点医学人才 江苏大学附属医院科技项目(No jdfyRC2015010) 江苏省高层次卫生人才“六个一工程”项目(No LGY2016055)
关键词 胞外囊泡 药物传递 天然纳米载体 免疫治疗 临床实验 研究进展 extracellular vesicles drug delivery natural nano-carriers immunotherapy clinical trial research progress
  • 相关文献

参考文献5

二级参考文献42

  • 1Farber HW, Loscalzo J. Pulmonary arterial hypertension. N Engl J Med 2004; 351; 1655-65.
  • 2Archer SL, Weir EK, Wilkins MR. Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapies. Circulation 2010; 121: 2045-66.
  • 3Zhang ZH, Lu Y, Luan Y, Zhao JJ. Effect of bone marrow mesenchymal stem cells on experimental pulmonary arterial hypertension. Exp Ther Med 2012; 4: 839-43.
  • 4Umar S, de Visser YP, Steendijk P, Schutte CI, Laghmani el H, Wagenaar GT, et al. AIIogenic stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension. Am J Physiol Heart Circ Physiol 2009; 297: H 1606-16.
  • 5Baber SR, Deng W, Master RG, Bunnell BA, Taylor BK, Murthy SN, et al. Intratracheal mesenchymal stem cell administration attenuates monocrotaline-induced pulmonary hypertension and endothelial dysfunction. Am J Physiol Heart Circ Physio12007; 292: Hl120-8.
  • 6Ratajczak J, Wysoczynski M, Hayek F, Janowska-Wieczorek A, Ratajczak MZ. Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia 2006; 20: 1487-95.
  • 7He J, Wang Y, Sun S, Yu M, Wang C, Pei X, et al. Bone marrow stem cells-derived microvesicles protect against renal injury in the mouse remnant kidney model. Nephrolol~ (Carlton) 2012; 17: 493-500.
  • 8Bruno S, Grange C, Deregibus MC, Calogero RA, Saviozzi S, Collino F, et al. Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J Am Soc Nephro12009; 20: 1053-67.
  • 9Gatti S, Bruno S, Deregibus MC, Sordi A, Cantaluppi V, Tetra C, et al. Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury. Nephrol Dial Transplant 2011; 26: 1474-83.
  • 10Xin H, Li Y, Cui Y, Yang J J, Zhang ZG, Chopp M. Systemic admini- stration of exosomes released from mesenchymal stromal cells promote functional recovery and neurovascular plasticity after stroke in rats. J Cereb Blood Flow Metab 2013; 33: 1711-5.

共引文献54

同被引文献34

引证文献5

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部